Orphan drugs Current Affairs, GK & News

Intas becomes India’s first company to launch Romiplostim to treat chronic ITP

Drug-maker Intas Pharmaceuticals Ltd has become the first company to launch Romiplostim in India under the brand name Romy for the treatment of chronic Immune Thrombocytopenia (ITP). ITP is an autoimmune blood disorder which leads to low platelet counts. The newly-launched drug will cost just one-fifth of the price of the current medication. It is ..

Topics: 

Short Note – Rare Diseases

A disease can be defined as a disorder in the structure/function of a living organism that is not the result of a past injury. What are rare diseases? Conventionally, a rare disease is one which affects only a small population of people living in a certain location. The most common rare diseases are haemophilia, thalassemia, ..

Category: 

Topics: